Pavel Anzenbacher heads the Department of Pharmacology at Palacky University, Olomouc (Czech Republic) and is vicepresident of the Czech Society of Clinical and Experimental Pharmacology and Toxicology. Having obtained his academic degrees from Charles University, Prague and from the Academy of Sciences of the Czech Republic he joined the Faculty of Medicine at Palacky University. His scientific contacts and stays have included e.g. the Princeton University, Vanderbilt University, Nashville, University of Connecticut, INSERM Montpellier, University of Lubeck, Technical University Berlin and Jagellonian University Cracow. Professor Anzenbacher has authored over 150 original scientific publications and has, among other honours, received the Fogarty Award of the USPHS.
Ulrich M. Zanger is deputy head of the Dr. Margarete
Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
(Germany). A chemist by training, he began to work on drug
metabolism at the Biocenter of the University of Basel,
Switzerland, where he obtained a PhD
degree in biochemistry. He undertook postdoctoral studies at the
Southwestern Medical Center at Dallas, Texas, before returning to
Basel and later moving to Stuttgart. His major research interests
are in human drug metabolizing cytochromes P450 and in basic and
clinical aspects
of pharmacogenetics/genomics. Professor Zanger has authored more
than 130 scientific articles and is lecturing in pharmacology and
toxicology at the University of Tubingen.
"Overall therefore, a book which can be read in its own right for the first half and then a valuable source of reference for the second half. A useful tome to have on the bookshelf for anyone in the field." (British Toxicology Society, 1 July 2013)
 |
Ask a Question About this Product More... |
|
